Home › Funds › BML Capital Management, LLC › PMVP
BML Capital Management, LLC position in PMVP
PMV PHARMACEUTICALS INC · Health Care
BML Capital Management, LLC reported holding 7,330,000 shares of PMVP (PMV PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$12.2M, representing 6.52% of its reported portfolio and ranking #4 among its reported holdings. BML Capital Management, LLC has disclosed PMVP holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How BML Capital Management, LLC's PMVP position evolved
BML Capital Management, LLC first disclosed a stake in PMVP in Q1 2024 at 1,306,490 shares (US$2.2M). The position peaked in Q3 2026 at 7,330,000 shares, worth US$12.2M. Across 11 filings, BML Capital Management, LLC increased the stake 7 time(s), trimmed it 0 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 7,330,000 shares valued at US$12.2M — an increase of 2,000,000 shares quarter over quarter.. Notable position changes include a 105% increase in Q4 2024 (shares fell 28% over the following quarter), a 33% increase in Q2 2025 (shares rose 32% over the following quarter), a 38% increase in Q3 2026 (shares fell 26% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 1.31M | $2.22M | New |
| Q2 2024 | 1.31M | $2.12M | Hold |
| Q3 2024 | 1.69M | $2.52M | Add |
| Q4 2024 | 3.47M | $5.23M | Add |
| Q1 2025 | 3.75M | $4.08M | Add |
| Q2 2025 | 5.00M | $5.30M | Add |
| Q3 2025 | 5.29M | $7.41M | Add |
| Q4 2025 | 5.29M | $6.62M | Hold |
| Q1 2026 | 5.32M | $6.60M | Add |
| Q2 2026 | 5.33M | $7.14M | Hold |
| Q3 2026 | 7.33M | $12.24M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PMVP and 13F data
PMVP (PMV PHARMACEUTICALS INC) is a Health Care company. 21 other funds we track also report a position in PMVP — the largest reported positions include TANG CAPITAL MANAGEMENT LLC (US$5.7M), Sio Capital Management, LLC (US$3.5M), Euclidean Capital LLC (US$3.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PMVP
- TANG CAPITAL MANAGEMENT LLC 4.25M sh · $5.69M · Q2 2026
- Sio Capital Management, LLC 2.63M sh · $3.53M · Q2 2026
- Euclidean Capital LLC 2.63M sh · $3.52M · Q2 2026
- Aldebaran Capital, LLC 489.54K sh · $817.53K · Q3 2026
More on BML Capital Management, LLC
FAQ
How long has BML Capital Management, LLC held PMVP?
BML Capital Management, LLC has disclosed PMVP holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
What is BML Capital Management, LLC's current position in PMVP?
As of Q3 2026, BML Capital Management, LLC holds 7.33M shares of PMVP (PMV PHARMACEUTICALS INC), valued at $12.24M, representing 6.52% of its reported portfolio and ranking #4.
Has BML Capital Management, LLC been buying or selling PMVP?
In the latest 13F filing (Q3 2026), BML Capital Management, LLC increased its position in PMVP. The position peaked in Q3 2026 at 7.33M shares.
Which other funds hold PMVP?
Other major institutional holders of PMVP include TANG CAPITAL MANAGEMENT LLC, Sio Capital Management, LLC, Euclidean Capital LLC, among 21 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.